Gene patents, health care policy and licensing schemes

Trends in Biotechnology
Timothy Caulfield, Barbara von Tigerstrom

Abstract

Human gene patents continue to stir social controversy, including the possibility that they might adversely affect public access to useful technologies. It has been suggested that a compulsory licensing policy might be used to alleviate the adverse effect of patents in this context. We suggest, however, that it is unclear whether existing international policies and licensing practices will permit compulsory licensing to be used in a way that would address common concerns. Indeed, given the minor role that genetic technologies have in most health care systems, it would be difficult to justify compulsory licensing. At a minimum, policy makers need to be more realistic about the potential effects of international trade agreements on the development of biotechnology policies.

References

Oct 5, 2001·JAMA : the Journal of the American Medical Association·K K SteinbergM J Khoury
Jan 29, 2003·The Journal of Molecular Diagnostics : JMD·Mildred K ChoJon F Merz
Oct 25, 2003·Science·Kathleen Ries Merikangas, Neil Risch
Mar 30, 2005·Lancet·Patrick A Messerlin
Sep 24, 2005·Science·John P WalshWesley M Cohen

❮ Previous
Next ❯

Citations

Jun 27, 2015·Health Care Analysis : HCA : Journal of Health Philosophy and Policy·Shawn H E Harmon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

© 2022 Meta ULC. All rights reserved